Survey on the safety of a no-updosing regimen of sublingual immunotherapy.
Musarra
A
A
Servizio Allergologia ASL 11, Reggio Calabria.
Cilia
M
M
Pecora
S
S
Passalacqua
G
G
D000286:Administration, Sublingual; D000293:Adolescent; D000328:Adult; D000485:Allergens / Q000008:administration & dosage / Q000627:therapeutic use*; D000528:Alternaria; D000818:Animals; D039741:Antigens, Dermatophagoides / Q000008:administration & dosage / Q000627:therapeutic use; D019306:Artemisia; D002648:Child; D002675:Child, Preschool; D003888:Desensitization, Immunologic / Q000009:adverse effects* / Q000379:methods; D004306:Dose-Response Relationship, Immunologic; D004334:Drug Administration Schedule; D005260:Female; D005500:Follow-Up Studies; D006306:Health Surveys; D006801:Humans; D008297:Male; D008499:Medical Records; D008875:Middle Aged; D031658:Olea; D032403:Parietaria; D010936:Plant Extracts / Q000008:administration & dosage / Q000627:therapeutic use; D006109:Poaceae; D011537:Pruritus / Q000139:chemically induced; D039981:Pyroglyphidae / Q000276:immunology
D000485:Allergens; D039741:Antigens, Dermatophagoides; D010936:Plant Extracts